Why the study?
Does the protectedness of an HTC identified by LGE-CMR predict arrhythmogenicity during ventricular tachycardia ablation?
Does the protectedness of an HTC identified by LGE-CMR predict arrhythmogenicity during ventricular tachycardia ablation?
LGE-CMR can identify the protectedness of heterogeneous tissue channels, which correlates with arrhythmogenicity during VT ablation.
LGE-CMR channel analysis may refine VT ablation targets; hypothesis-generating and requires prospective validation before clinical adoption.
The protectedness of an HTC identified by LGE-CMR is strongly related to its arrhythmogenicity during VT ablation.
No takes yet. Share an insight, caveat, or question.
Sánchez-Somonte et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: